Biostate

Country: New Zealand

Bahasa: Inggeris

Sumber: Medsafe (Medicines Safety Authority)

Bahan aktif:

Dried factor VIII fraction 250 [iU]; von Willebrand's factor : Ristocetin cofactor 500 [iU]

Boleh didapati daripada:

CSL Behring (NZ) Ltd

INN (Nama Antarabangsa):

Dried factor VIII fraction 250 IU

Dos:

250 IU

Borang farmaseutikal:

Injection with diluent

Komposisi:

Active: Dried factor VIII fraction 250 [iU] von Willebrand's factor : Ristocetin cofactor 500 [iU] Excipient: Albumin Calcium chloride dihydrate Plasma protein Sodium chloride Sodium citrate dihydrate Sucrose Trometamol Water for injection

Unit dalam pakej:

Combination pack, Vial + Diluent, 1 dose unit

Kelas:

General sale

Jenis preskripsi:

General sale

Dikeluarkan oleh:

CSL Behring (Australia) Pty Ltd

Tanda-tanda terapeutik:

Biostate® is indicated for: · the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated

Ringkasan produk:

Package - Contents - Shelf Life: Combination pack, Vial + Diluent - 1 dose units - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light. one excursion of up to 6 months at 25°C allowed - Vial, glass, Diluent - 5 mL - 60 months from date of manufacture stored at or below 25°C - Vial, glass, Lyophilised powder - 250 IU - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light. one excursion of up to 6 months at 25°C allowed

Tarikh kebenaran:

1999-01-29

Ciri produk

NEW ZEALAND DATA SHEET
Biostate NZ DS 20.00
Page 1 of 20
1 PRODUCT NAME
Biostate
®
250 IU FVIII/500 IU VWF powder and diluent (5 mL) for solution for
injection
Biostate
®
500 IU FVIII/1000 IU VWF powder and diluent (5 mL) for solution for
injection
Biostate
®
500 IU FVIII/1000 IU VWF powder and diluent (10 mL) for solution for
injection
Biostate
®
1000 IU FVIII/2000 IU VWF powder and diluent (10 mL) for solution for
injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Biostate
®
is a high purity, sterile, powder for injection containing a human
coagulation factor VIII
(FVIII) and human von Willebrand factor (VWF) complex.
Biostate
®
is manufactured from human plasma donated by New Zealand’s voluntary
non-remunerated
donors. The FVIII/VWF complex in Biostate
®
is purified from cryoprecipitate using selective
precipitation and size exclusion chromatography steps. It contains
other proteins such as fibrinogen,
fibronectin, immunoglobulins (IgA, IgM, IgG) and transforming growth
factor-β (TGF-β) all of which
are present at significantly lower levels than in normal plasma.
Biostate
®
250 IU FVIII/500 IU VWF powder and diluent for solution for injection
One vial of powder contains nominally:
-
250 IU human coagulation factor VIII (FVIII).
-
500 IU human von Willebrand factor (VWF).
After reconstitution with the 5 mL water for injections provided, the
solution contains 50 IU/mL of
FVIII and 100 IU/mL of VWF.
Biostate
®
500 IU FVIII/1000 IU VWF powder and diluent for solution for injection
One vial of powder contains nominally:
-
500 IU human coagulation factor VIII (FVIII).
-
1000 IU human von Willebrand factor (VWF).
After reconstitution with the 10 mL water for injections provided, the
solution contains 50 IU/mL of
FVIII and 100 IU/mL of VWF.
Biostate
®
500 IU FVIII/1000 IU VWF powder and diluent for solution for injection
One vial of powder contains nominally:
-
500 IU human coagulation factor VIII (FVIII).
-
1000 IU human von Willebrand factor (VWF).
After reconstitution with the 5 mL water for injecti